An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy

Echocardiography

Volumn 22, Issue 7, 2005, Pages 547-554

  Rahko, Peter S ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Section of Cardiovascular Medicine   (United States)

Author keywords

Adrenergic beta blockade; Carvedilol; Dilated cardiomyopathy; Heart failure

Indexed keywords

CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; LOOP DIURETIC AGENT; NITRIC ACID DERIVATIVE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE VOLUME; HEART PERFORMANCE; HEART STRESS; HEART VENTRICLE REMODELING; HEART VENTRICLE WALL; HUMAN; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; CARDIOMYOPATHY, DILATED; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 27744493547     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2005.40057.x     Document Type: Article

References (35)

1. Packer M, Bristow MR, Cohn JN, et al: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
2. Australia/New Zealand Heart Failure Research Collaborative Group: Randomized placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet 1997;349:375-380.
3. Merit-HF Study Group: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-2007.
4. CIBIS II Investigators and Committees: The cardiac insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial. Lancet 1999;353:9-13.
5. Poole-Wilson PA, Swedberg K, Cleland JG, et al: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European Trial (COMET). Lancet 2003;362:7-13.
6. Eichhorn EJ, Bristow MR: Medical therapy can improve the biologic properties of the chronically failing heart: A new era in the treatment of heart failure. Circulation 1996;94:2285-2296.
7. Eichhorn EJ, Bedotto JB, Malloy CR, et al: Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure: Improvements in hemodynamic, contractile and diastolic performance with bucindolol. Circulation 1990;82:473-483.
8. Eichhorn EJ, Heesch CM, Barnett JH, et al: Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized double blind placebo-controlled study. J Am Coll Cardiol 1994;24:1310-1320.
9. Wisenbaugh T, Katz I, Davis J, et al: Long term (3-month) effects of a new beta blocker (Nebivolol) on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 1993;21:1094-1100.
10. Remme WJ, Riegger G, Hildebrandt P, et al: The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction: The carvedilol and ACE-inhibitor remodeling mild heart failure trial (CARMEN). Cardiovasc Drugs Ther 2004;18:57-66.
11. Doughty RN, Whalley GA, Gamble G, et al: Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic disease. J Card Fail 2000;6:11-18.
12. Quaife RA, Gilbert EM, Christian PE, et al: Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am J Cardiol 1996;78:779-784.
13. Doughty RN, Whalley GA, Gamble G, et al: Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 1997;29:1060-1066.
14. Gilbert EM, Anderson JL, Deitchman D, et al: Long term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double blind randomized study of bucindolol versus placebo. Am J Med 1990;88:223-229.
15. Andersson B, Caidahl K, Waagstein F: Recovery from left ventricular asynergy in ischemic cardiomyopathy following long term beta blockade treatment. Cardiology 1994;85:14-22.
16. Australia-New Zealand Heart Failure Research Collaborative Group: Effect of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic disease. Circulation 1995;92:212-218.
17. Hall SA, Cigarna CG, Marcoux L, et al: Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 1995;25:1154-1161.
18. Lowes BD, Gill EA, Abraham WT, et al: Effects of carvedilol on left ventricular mass chamber geometry and mitral regurgitation in chronic heart failure. Am J Cardiol 1999;83:1201-1205.
19. Sahn DJ, DeMaria A, Kisslo J, et al: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1082.
20. Douglas PS, Morrow R, Ioli A, et al: Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989;13:311-315.
21. Mirsky I: Review of various theories for evaluation of left ventricular wall stress (Ch. 13). In Mirsky I, Chiston DN, Sandler H (eds): Cardiac Mechanics: Physiological, Clinical and Mathematical Considerations. New York, John Wiley & Sons, 1974.
22. Schiller NB, Shah PN, Crawford M: Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-367.
23. Compomolla S, Febo O, Gnemmi M, et al: Beta-blockade therapy in chronic heart failure: Diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000;139:596-608.
24. Andersson B, Caidahl K, di Lenarda A, et al: Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation 1996;94:673-682.
25. Helmcke F, Nanda NC, Hsiung MC, et al: Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-183.
26. Glantz SA: Primer of Biostatistics, 3rd Ed. New York, McGraw-Hill Inc., 1992, pp. 320-352.
27. Cohn JN, Ferrari R, Sharpe N: Cardiac remodeling concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000;35:569-582.
28. Konstam MA, Kronenberg MW, Rosseau MF, et al: Effects of the angiotensin converting enzyme inhibitor enalapril on the long term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. Circulation 1993;88(Part I):2277-2283.
29. Greenberg B, Quinones MA, Koilpillai C, et al: Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: Results of the SOLVD echocardiography substudy. Circulation 1995;91:2573-2581.
30. Konstam MA, Rousseau MF, Kronenberg MW, et al: Effects of the angiotensin converting enzyme inhibitor enalapril on the long term progression of left ventricular dysfunction in patients with heart failure. Circulation 1992;186:431-438.
31. St. John Sutton M, Pfeffer MA, Moye L, et al: Cardiovascular death and left ventricular remodeling two years after myocardial infarction: Baseline predictors and impact of long term use of captopril information from the survival and ventricular enlargement (SAVE) trial. Circulation 1997;96:3294-3299.
32. Brunner-La Rocca HP, Vaddadi G, Estev M: Recent insights into therapy of congestive heart failure: Focus on ACE inhibition and angiotensin-II antagonism. J Am Coll Cardiol 1999;33:1163-1173.
33. Metra M, Giubbini R, Nodari S, et al: Differential effects of blockers in patients with heart failure: A prospective randomized double blind comparison of the long term effects of metoprolol versus carvedilol. Circulation 2000;102:546-551.
34. Traversi E, Pozzoli M, Cioffi G, et al: Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with heart failure. Am Heart J 1996;132:809-819.
35. Pozzoli M, Traversi E, Cioffi G, et al: Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation 1997;95:1222-1230.